Subscribe to RSS

DOI: 10.1055/s-0045-1809175
Fear of Cancer Recurrence and Coping among Breast Cancer Survivors among Indian Females: A Longitudinal Study
Funding None.

Abstract
Introduction
Breast cancer survivors (BCSs) may experience a cascade of negative reactions during the entire treatment process. Post-treatment, the most common challenge among all fears is cancer recurrence. The fear brings many forms of psychological morbidity during follow-up. However, coping throughout and beyond cancer helps survivors hold a strong pillar of support as part of backup.
Objective
This study aims to assess the interplay of the fear of cancer recurrence (FCR) and how it impacts the distress and relation of coping with recurrence.
Materials and Methods
A longitudinal study was conducted in a tertiary care center in North India: T1 (January 2021–April 2021) and T2 (May 2023–September 2023). A total of 700 BCSs were approached initially, and after 2 years, they were again screened using the purposive sampling technique. Statistical Package for Social Sciences (SPSS) 23 was used to analyze the data.
Results
The patients' mean age ( standard deviation [SD]) was 48.14 (8.53) years. The mean (SD) FCR score was 15.26 (4.45). There was an inverse association between the FCR score and the coping score. The higher the age, the lesser the FCR score and the better religious coping.
Conclusion
Psychological FCR is a detachable part of patients' worry once a person is diagnosed with any threatening illness. The coping mechanism should be strengthened by providing psychosocial interventions, family therapy, and other individual-centered therapies.
Keywords
breast cancer survivor - fear of cancer recurrence - coping - psychological distress - depression - women - IndiaData Availability Statement
Author elects to not share data.
Patient's Consent
Informed consent was obtained from the patient before participating in the study.
Publication History
Article published online:
20 May 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Simard S, Savard J. Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv 2015; 9 (03) 481-491
- 2 Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 2005; 44 (Pt 2): 227-239
- 3 Kumar K, Kumar S, Mehrotra D, Tiwari SC, Kumar V, Dwivedi RC. Reliability and psychometric validity of Hindi version of Depression, Anxiety and Stress Scale-21 (DASS-21) for Hindi speaking Head Neck Cancer and Oral Potentially Malignant Disorders Patients. J Cancer Res Ther 2019; 15 (03) 653-658
- 4 Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med 1997; 4 (01) 92-100
- 5 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68 (06) 394-424
- 6 Malvia S, Bagadi SA, Dubey US, Saxena S. Epidemiology of breast cancer in Indian women. Asia Pac J Clin Oncol 2017; 13 (04) 289-295
- 7 Kim Y, Carver CS, Spillers RL, Love-Ghaffari M, Kaw CK. Dyadic effects of fear of recurrence on the quality of life of cancer survivors and their caregivers. Qual Life Res 2012; 21 (03) 517-525
- 8 Lebel S, Rosberger Z, Edgar L, Devins GM. Emotional distress impacts fear of the future among breast cancer survivors not the reverse. J Cancer Surviv 2009; 3 (02) 117-127
- 9 Vickberg SMJ. The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med 2003; 25 (01) 16-24
- 10 Brandberg Y, Sandelin K, Erikson S. et al. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 2008; 26 (24) 3943-3949
- 11 Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 2005; 330 (7493) 702
- 12 Luigjes-Huizer YL, Tauber NM, Humphris G. et al. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psychooncology 2022; 31 (06) 879-892
- 13 Thakur M, Sharma R, Mishra AK, Singh K. Posttraumatic growth and psychological distress among female breast cancer survivors in India: a cross-sectional study. Indian J Med Paediatr Oncol 2022; 43 (02) 165-170
- 14 Folkman S, Lazarus RS. Coping as a mediator of emotion. J Pers Soc Psychol 1988; 54 (03) 466-475
- 15 Hajian S, Mehrabi E, Simbar M, Houshyari M. Coping strategies and experiences in women with a primary breast cancer diagnosis. Asian Pac J Cancer Prev 2017; 18 (01) 215-224
- 16 Thakur M, Gupta B, Kumar R. et al. Coping among women diagnosed with breast cancer with co-morbid depression: a study from North India. Delhi Psychiatry J 2018; 21: 358-365
- 17 Gupta B, Yaduvanshi R, Trivedi JK, Nischal A. A comparative study of body image and coping style in breast cancer patients. Delhi Psychiatry J 2012; 15 (01) 177-182
- 18 Thakur M, Sharma R, Mishra AK, Gupta B. Body image disturbances among breast cancer survivors: a narrative review of prevalence and correlates. Cancer Res Stat Treat 2022; 5 (01) 90
- 19 Almaraz D, Saiz J, Moreno Martín F. et al. Religiosity, emotions and health: the role of trust/mistrust in god in people affected by cancer. Healthcare (Basel) 2022; 10 (06) 1138
- 20 Taylor EJ, Petersen C, Oyedele O, Haase J. Spirituality and spiritual care of adolescents and young adults with cancer. Semin Oncol Nurs 2015; 31 (03) 227-241